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A total of 416 actinomycete cultures were isolated from various unique environments
in Ethiopia and tested for bioactivity. Six isolates with pronounced antimicrobial activity
were chosen for taxonomic identification and further investigation. Morphological and
cultural properties of the isolates were found to be consistent with those of the genus
Streptomyces, which was further confirmed by phylogenetic analysis based on 16S
rRNA gene sequences. One of the isolates, designated Streptomyces sp. Go-475,
which displayed potent activity against both pathogenic yeasts and Gram-positive
bacteria, was chosen for further investigation. Metabolite profiles and bioactivity of
Go-475 incubated on wheat bran-based solid and soya flour-based liquid media
were compared using high-resolution LC-MS. This allowed identification of several
known compounds, and suggested the ability of Go-475 to produce new secondary
metabolites. Major anti-bacterial compounds were purified from liquid cultures of
Go-475, and their structures elucidated by NMR andHRMS as 8-O-methyltetrangomycin
and 8-O-methyltetrangulol. In addition, many potentially novel metabolites were
detected, the majority of which were produced in solid media-based fermentation.
The genome sequence of Streptomyces sp. Go-475 was obtained using a hybrid
assembly approach of high quality Illumina short read and low quality Oxford Nanopore
long read data. The complete linear chromosome of 8,570,609 bp, featuring a G+C
content of 71.96%, contains 7,571 predicted coding sequences, 83 t(m)RNA genes,
and six rrn operons. Analysis of the genome for secondary metabolite biosynthesis
gene clusters further confirmed potential of this isolate to synthesize chemically diverse
natural products, and allowed to connect certain clusters with experimentally confirmed
molecules.
Keywords: ethiopian soils, Streptomyces, solid state fermentation, antimicrobial assays, high resolution mass
spectrometry, NMR-assisted structure elucidation, genome analyses
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INTRODUCTION
Actinomycete bacteria have a widely recognized potential for
the production of bioactive secondary metabolites and valuable
enzymes (van derMeij et al., 2017). These Gram-positive bacteria
belonging to the order Actinomycetales are abundant in soils,
marine sediments as well as being associated with various plants
and animals (Goodfellow andWilliams, 1983). Most importantly,
secondary metabolites of actinomycetes play a prominent role in
the history of drug development, in particular as antibiotics and
anticancer agents (Katz and Baltz, 2016). During the golden age
of natural product-based drug discovery (1950s through 1970s),
most of the antibiotics currently used to treat various infections
were discovered from actinomycetes; e.g., the antifungals
nystatin and amphotericin or the antibacterials erythromycin
and vancomycin. Besides antibiotics, actinomycetes are known to
produce antitumor agents (Li et al., 2008), immunosuppressants,
pesticides, herbicides, and anthelmintics (El-Tarabily et al., 2009;
Liu et al., 2009; Nakouti et al., 2012). Actinomycetes of the
genus Streptomyces are the most versatile producers of bioactive
secondary metabolites and they continue to be interesting
sources for the discovery of new antibiotics (Berdy, 2005; Baltz,
2007; Demain, 2009). Streptomycetes usually possess 20–50 gene
clusters dedicated to the biosynthesis of secondary metabolites
in their genomes, underscoring their potential for the discovery
of new bioactive compounds (Nett et al., 2009). Most of such
clusters remain “silent” in laboratory conditions, but tools are
being developed for activation of these genes, thus prompting
production of previously undetected compounds (Kealey et al.,
2017).
Despite the onset of the genomic era and some progress
in awakening “silent” gene clusters in actinomycetes, screening
for new natural products remains an important part in the
drug discovery process. The major challenge in this approach
remains the re-discovery of already known bioactive compounds,
even from phylogenetically distinct actinomycetes. Therefore,
efficient de-replication (Carrano and Marinelli, 2015), novel
screening techniques, and investigating new sample sources
from underexplored habitats (Nolan and Cross, 1988; Tan
et al., 2009; Goodfellow et al., 2010) become more and more
important. In search for actinomycetes capable of producing
novel bioactive metabolites, it appears especially beneficial to
look into extreme habitats and unique environmental niches
(Sanglier et al., 1996; Bull and Stach, 2007; Berdy, 2012; Matsui
et al., 2012; Zotchev, 2012). In this regard, Ethiopian soils from
various climatic zones possessing remarkable biodiversity may
harbor new actinomycete strains that have the potential for new
antibiotic discovery.
The current work was aimed at the isolation of antibiotic-
producing actinomycetes from soils collected at various unique
environments and specific biotopes in Ethiopia, with Ataye,
Dengego, Gode, and Menagesha yielding bioactive isolates that
were closely investigated in this study. Map of the region and
the description of collection sites are provided in Figure S1
and its legend (Supplementary Materials). Standard screening
methods were employed for initial detection of antimicrobial
activities of the isolates, targeting known microbial pathogens.
This was followed by taxonomic identification of the most
active isolates and their bioactivity profiling. The genome of one
isolate was sequenced, analyzed for the presence of secondary
metabolite biosynthesis gene clusters (BGCs), and secondary
metabolite profiles of its extracts were investigated using high-
resolution MS. Both the genome and the metabolite profiles
suggest potential for production of many presumably novel
compounds. Identities of two known compounds were confirmed
via isolation and NMR-assisted structure elucidation, and gene
cluster for their biosynthesis was identified.
MATERIALS AND METHODS
Soil Sampling and Isolation of
Actinomycetes
The sample collection sites encompassed 13 specific habitats in
five geographical regions, with diverse natural environments.
Specific soil sampling locations and their corresponding
coordinates are presented in Table S1 (Supplementary Materials).
Soil samples were collected using sterile spatula by removing 2–
3 inches of top soil and placing the material in sterile zipped
polythene bags (Bharti et al., 2010). Sample bags were labeled
according to their source and collection time. The collected soil
samples were transported to the Microbiology Laboratory (Addis
Ababa University) for isolation of bacteria.
Actinomycete cultures were isolated by soil serial dilution
plating technique on various media including starch casein
agar, starch nitrate agar, yeast malt extract agar, and
actinomycete isolation agar medium supplemented with
50µg/ml cycloheximide and 25µg/ml nystatin. The cultures
were incubated at 30 ± 2◦C for 7–12 days. Observation was
made daily during incubation period for colony growth (Okazaki
et al., 1983; Hayakawa and Nonomura, 1987; Seong et al.,
2001). Morphologically identified colonies and those showing
a characteristic inhibition (clear zone) in the crowded plate
were picked up with sterile wire loop and streaked on starch
casein agar medium, yeast malt extract agar medium plates,
and actinomycete isolation agar medium and incubated at 30◦C
for 7–12 days. Repeated re-streaking was conducted for further
purification of the cultures. Pure actinomycete cultures were
stored at 4◦C on starch casein agar slants for further work.
Taxonomic Identification of Selected
Isolates
Morphological and cultural characteristics of the isolates were
determined as per the international streptomyces project
guidelines (Shirling and Gottlieb, 1966). Micro-morphological
structures of the isolates were studied as described in Williams
and Cross (1971) and Williams et al. (1989) using a cover slip
technique. The structure of the hyphae and the spore chain
morphology were investigated using a light microscope (model
BX-51; Olympus, Tokyo, Japan).
Identification of actinomycetes to the genus level was done
by a polyphasic approach, including cultural, morphological,
physiological, and biochemical characteristics as described in
Basilio et al. (2003). Taxonomic identification of the isolates
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was also verified by the 16S rRNA gene sequence analysis.
Genomic DNA of the isolates grown in 3% TSB medium (24–
48 h, 28◦C, 200 rpm) was extracted with DNeasy Tissue Kit
(QIAGEN) following the instructions from the manufacturer.
PCR amplification of the 16S rDNA fragments was performed
using 27f and 1492r primers designed by Weisburg et al. (1991),
and PCR products were directly sequenced at Eurofins Scientific
(Austria) using the same primers. Phylogeny was inferred using
the software MEGA7 (Kumar et al., 2016). Nucleotide sequences
were deposited to the GenBank under accession numbers as
follows: MF474325 (Ac-146), MF474326 (Go-475), MF474327
(Ac-123), MF474328 (Ed-065), MF474329 (Ru-355), MF474330
(Ac-006).
Solid and Liquid State Fermentations and
Preparation of Extracts
The inoculum for each of the selected isolates was prepared by
inoculating three loopfulls of the spores in 250mL Erlenmeyer
flasks containing 50mL of liquid ISP2 medium and incubating at
30◦C on a rotary shaker (200 rpm) for 7 days. On the seventh day
the culture was transferred to sterile test tubes and centrifuged
at 2,000 rpm. The supernatant was discarded and the culture
pellet was resuspended in 0.1M phosphate buffer (pH 7.0) and
0.01% of sterile Tween 80 was added. The suspension prepared in
such a way was used as an inoculum for solid state fermentation
(SSF) experiments. For the SSF, 10 g of the solid substrate (wheat
bran) was placed in 250mL Erlenmeyer flasks and supplemented
with 15.75mL mineral salt solution containing 0.1% NaCl,
0.1% MgSO4, 0.5% NH4NO3, and 0.2% KH2PO4 supplemented
with 1% each of soluble starch and peptone to produce
moisture content of 65%. One milliliter of a trace elements
solution containing (g/l): CuSO.45H2O, 3.3; FeSO
.
47H2O, 10.0;
ZnSO.47H2O, 50.0; MnSO
.
42H2O, 4.0; CoCl2, 2.0; (NH4)2MoO4,
1.0, was added. Three mL of inoculum suspensions (containing
2.8 × 106 CFU/mL) was added, shacked well to distribute the
inoculum uniformly and incubated at 30◦C for 12 days (Bussari
et al., 2008). At the end of the fermentation process, methanol
extracts were prepared as described in Venkateshwarlu et al.
(2000).
For the liquid state fermentations (LSF), 15mL of TSB
medium (Oxoid, UK) was inoculated with 200 µL of spore
suspension of isolate Go-475 in a 100mL Erlenmeyer flask
and incubated at 28◦C with 200 rpm for 48 h to produce
seed culture. The mycelium was collected by centrifugation
and then resuspended in 10mL sterile 20% glycerol solution
for preparation of stocks. Two-hundred and fifty milliliters of
medium 5288 (Soy flour 10 g, Glycerol 15 g, NaCl 5 g, CaCO3
1 g, CoCl.27H2O 1mg, in 1 L of distilled water according to
Wink, 2012) were inoculated with 5mL of seed culture stock and
fermented in 2 L baffled Erlenmeyer flasks at 28◦C with 200 rpm
for 7 days. The whole culture was freeze-dried and extracted with
50mL of methanol.
Antimicrobial Activity Testing
Primary screening for antifungal activity was performed for all
pure actinomycete cultures using the agar plug method (Bharti
et al., 2010) withCandida albicansATCC 62376 andCryptococcus
neoformans (clinical isolate) as test organisms. The experiments
were conducted in triplicates and the bioactivity of the isolates
was assessed by the formation of an inhibition zone around the
plug.
The bioactivity testing of the methanol extracts obtained from
the isolates selected based on primary screening results was
done for C. albicans and C. neoformans using the disc diffusion
assay method (Galvan et al., 2008). Disc diffusion assay method
described in CLSI (2012) was used for antibacterial susceptibility
testing with the test organisms Staphylococcus aureus ATCC
25923, Bacillus subtilis ATCC 6633, Escherichia coli ATCC 25922,
Salmonella typhimuriumATCC 6539, and Shigella boydii (clinical
isolate). Description of the clinical isolates used as test organisms
in antimicrobial assays is given in Supplementary Materials.
All the secondary bioactivity tests with crude extracts were
conducted in triplicates and inhibition zone diameters were
measured. The data were analyzed by one- way- ANOVA and the
mean separation was achieved by the Duncan’s multiple range
tests, the mean ±SD was used for interpretation of the data,
using SPSS (version 20). Numerical differences were considered
as significant at the probability level of p ≤ 0.05.
Minimum inhibitory concentrations of the crude extract
from Streptomyces sp. Go-475 was determined for C. albicans
ATCC 62376 using the protocol described in NCCLS (2002)
and for B. subtilis ATCC6633 as described in CLSI (2012). The
experiment was performed in Muller Hinton Broth (MHB) for
B. subtilis whereas; Roswell Park Memorial Institute (RPMI) was
used for C. albicans. Two fold serial dilutions of the extract
in dimethyl sulfoxide were used. Inoculum suspensions of the
overnight grown C. albicans and B. subtilis were prepared in
sterile normal saline (0.85%) with direct colony suspension
method and the optical density was adjusted to 0.5 Mcfarland
standards at a wave length of 530 nm. The inoculum for B. subtilis
was diluted to a final working count of 2× 108 CFU/mL whereas
for C. albicans 2.5 × 103 CFU/mL was used. The experiments
were conducted with concentrations of the extract ranging from
0.39 to 800µg/mL. The cultures were incubated at 37◦C for
24 h and inspected visually; the lowest concentrations of the
extract that completely inhibited growth of the test organism
were considered as MIC values.
LC-MS Profiles of Crude Extracts of the
Isolate Go-475
To identify the antimicrobial compounds in the active extracts,
an analytical strategy previously established was employed
(Ladurner et al., 2017). The crude extracts obtained from both
SSF and LSF were diluted to a concentration of 1 mg/mL and first
analyzed by high-performance liquid chromatography (HPLC)
on an UltiMate 3000 RSLC-series system (Dionex/Thermo
Fisher Scientific, Germering, Germany) coupled in parallel to a
Corona ultra RS charged aerosol detector (CAD, Dionex/Thermo
Fisher Scientific) and an HCT 3D quadrupole ion trap mass
spectrometer (MS) equipped with an orthogonal ESI source
(Bruker Daltonics, Bremen, Germany). The CAD detector allows
the relative quantification of the non-volatile constitutes and thus
the identification of the main compounds, while the diode-array
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detector (DAD) and the MS provide qualitative information.
Separation was carried out on a Synergi 4u MAX-RP 80Å, 150
× 4.60mm, 4µmHPLC column (Phenomenex) using water and
acetonitrile as mobile phase A and B, respectively. The gradient
started from 50 to 95% B in 40min, followed by a washing
(10min at 95% B) and re-equilibration step (10min at 50% B).
The flow rate was 1.0 ml/min and the column oven temperature
was set to 35.0◦C. After passing the DAD, the eluate flow was
split 4:1 between the CAD and the MS, respectively. The CAD
nebulizer temperature was 35◦C and the ESI ion source was
operated as follows: capillary voltage:+3.5/−3.7 kV, nebulizer: 26
psi (N2), dry gas flow: 9 L/min (N2), and dry temperature: 340◦C.
Positive and negative ion mode multistage mass spectra up to
MS3 were obtained in automated data-dependent acquisition
(DDA) mode using helium as collision gas, an isolation window
of 1m/z = 4, and a fragmentation amplitude of 1.0 V.
In the next step, high-resolution mass spectra were recorded
on a maXis HD ESI-Qq-TOF mass spectrometer (Bruker
Daltonics) that was also connected to an UltiMate 3000 RSLC-
series system. The separation was performed with the above
described HPLC methods. The eluate flow was split∼1:8 and the
following ESI ion source settings were applied: capillary voltage:
±4.5 kV, nebulizer: 0.8 bar (N2), dry gas flow: 7.0 L/min (N2), and
dry temperature: 200◦C. The sum formulas of the detected ions
were determined using Bruker Compass DataAnalysis 4.2 based
on the mass accuracy (1m/z ≤ 10 ppm) and isotopic pattern
matching (SmartFormula algorithm). All collected MS data are
presented in Supplementary Materials.
Purification of Antibacterial Compounds
and NMR-Based Structure Elucidation
The crude extract (500mg) was mixed with Silica gel 60
from MERCK (particle size 0.063–0.200 nm for column
chromatography) in a proportion 1:2 and packaged in cartridge.
For fractionation the PuriFlash column 15 C18 HQ 35G−35.0 g
(22 bar) was used with a gradient of 5–98% Methanol/H2O in
50min and a flow of 15 mL/min using an equipment PuriFlash
420. One-hundred and nine Fractions of 0.5ml were collected,
freeze dried, and concentrated in methanol for antimicrobial
bioassays. The identification of the antimicrobial compounds
in the active fractions was similar as described above for the
crude extracts, but the HPLC separation was as given in detail in
Ladurner et al. (2017), whereby the gradient used in this study
was: 5–95% B in 45min followed by a washing (10min at 95% B)
and re-equilibration step (10min at 5% B).
NMR spectra were recorded on a Bruker Avance 500 NMR
spectrometer (UltraShield) using a 5mm switchable probe
(TCI Prodigy Kryo-probe head, 5mm, tripel resonance-invers-
detection probe head) with z axis gradients and automatic
tuning and matching accessory (Bruker BioSpin). The resonance
frequency for 1HNMRwas 500.13MHz and for 13CNMR 125.75
MHz. All measurements were performed for a solution in fully
deuterated chloroform or methanol at 298K. Standard 1D and
gradient-enhanced (ge) 2D experiments, like double quantum
filtered (DQF) COSY, HSQC, and HMBC, were used as supplied
by the manufacturer. Chemical shifts are referenced internally
to the residual, non-deuterated solvent signal for chloroform
1H (δ 7.26 ppm) or methanol (δ 3.31 ppm) and to the carbon
signal of the solvent for chloroform 13C (δ 77.00 ppm) or
methanol (δ 49.00 ppm). Chemical shifts for compounds 8-O-
methyltetrangomycin (1) and 8-O-methyltetrangulol (2), as well
as recorded NMR spectra are given in Supplementary Materials.
Genome Sequencing and Analyses
For sequencing of the genome of isolate Go-475, 1 µg of
chromosomal DNA was used for generation of a shotgun library
(TruSeq PCR-free sequencing library, Illumina Inc.) that was
sequenced applying the 2 × 300 bp sequencing protocol on an
Illumina MiSeq system as described previously (Zimmermann
et al., 2016). The data were assembled using Newbler v.2.8
(Roche), resulting in 423 scaffolds containing 492 contigs.
Subsequently, 2 µg of the Go-475 genomic DNA was used
for generation of a second shotgun library for sequencing on
the MinION system (Oxford Nanopore Technologies). Size-
selected DNA-fragments of 6–50 kb were used to create a 1D2
sequencing library according to the manufacturer’s instructions.
Subsequently, the sequencing mix was added to a R9.5 Flowcell
for a 24 hours run on the MinION Sequencer. Base calling and
data conversion was performed in parallel using Albacore v1.2.4
(Oxford Nanopore Technologies). The sequences were exported
in FASTQ format and used for an assembly with CANU v1.5
(Koren et al., 2017). After assembly, the resulting 4 contigs were
polished with the short Illumina reads using PILON (Walker et al.,
2014). The final assembly was done manually using CONSED
(Gordon and Green, 2013) to combine the contigs of the Newbler
and CANU assemblies. Gene prediction and annotation of the
finished genome were performed using the program PROKKA
(Seemann, 2014). The complete genome sequence was deposited
to DDBJ/ENA/GenBank under the accessions no. CP026121.
Analysis of the genome for secondary metabolite BGCs was
performed using online version of antiSMASH 4.02 (Blin et al.,
2017), followed by manual curation.
RESULTS
Actinomycete Isolation and
Characterization
A total of 416 soil actinomycetes were isolated from 13 different
understudied habitats in five geographical regions in Ethiopia
[see Figure S1 and Table S1 (Supplementary Materials) for
locations]. The number of actinomycete cultures obtained varied
in each sampling site. Among all the sampling sites, soil samples
from Menagesha Suba protected forest (one of the Ethiopian
national parks) located in the central region, contributed the
highest number of actinomycete cultures (31%), while Ataye
located in Ethiopian rift valley area yielded the least number
of isolates (7%). Isolates obtained from the Mengaesha Suba
protected forest were also rather diverse with respect to colony
color, shape, and texture (data not shown).
During the primary antimicrobial activity screening of
methanol extracts obtained from solid-state fermentation (SSF)
all the 416 isolates were tested for antifungal activity against
C. albicans and C. neoformans. The results showed that the
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extracts from 101 (24%) isolates were inhibiting the growth of C.
albicans, extracts from 88 (21%) isolates were inhibiting both C.
albicans and C. neoformans. Extracts from six isolates that were
most active in this primary screen, namely those designated Ac-
006, Ac-123, Ac-146, Ed-065, Go-475, and Ru-355, were selected
for further characterization. Isolates Ac-006, Ac-123, and Ac-146
were obtained fromMenagesha suba forest, Ed-065 was obtained
from Dengego, Go-475 from Gode and Ru-355 from the Ataye
region (see map on Figure S1).
First, cultural properties of these isolates were determined
using standard culture media and guidelines recommended by
the International Streptomyces Project. The data obtained in
these experiments are presented in Tables S2, S3 (Supplementary
Materials). Selected isolates were identified on the genus level
using 16S rDNA gene sequences obtained after amplification
from genomic DNA. All sequences were analyzed using the RDP
database, which clearly indicated that all analyzed isolates belong
to the genus Streptomyces. Next, the phylogenetic relationships
of the isolates to type strains and best matches according to
the nucleotide BLAST search were inferred using the Maximum
Likelihood algorithm in MEGA 7 software (Kumar et al., 2016).
According to the phylogenetic tree presented in Figure 1, isolates
Ac-006, Ac-123, Go-475, and Ru-355 all belonged to distinct
clades, while Ed-065 andAc-146 showed identical 16S rRNA gene
sequences and thus appeared to belong to the same clade.
Growth characteristics of the six selected Streptomyces spp.
were examined at different temperatures and pH levels. The
results showed that most cultures were able to grow well between
20 and 35◦C and at pH values between 6.5 and 8.5. The observed
optimum growth for most of the isolates was at 30◦C and pH
7.5. Most isolates were positive for starch hydrolysis, chitinase,
oxidase, and catalase tests, and showed a negative result for
indole production. However, Ac-006 was oxidase negative (Table
S4, Supplementary Materials). Streptomyces pp. Ac-029, Ac-123,
Ac-146, and Go-475 were found to be positive for melanin
production.
Bioactivities of Six Selected Streptomyces
Isolates
The methanol extract from isolate Go-475 manifested the
highest antifungal activity, followed by those of Ru-355 and Ed-
065 (Table 1). The bioactivity spectrum of the crude extracts
evaluated against bacterial pathogens generally showed better
activities against Gram-positive bacteria, with the highest activity
detected for the extract from Go-475 against B. subtilis, followed
by those from Ru-355 and Ed-065. Only few isolates showed
activity against Gram-negative bacteria in these tests; most
pronounced was that of Ru-355 (Table 1). Interestingly, isolates
Ac-146 and Ed-065 which, according to the 16S rDNA sequences,
are closely related, displayed different bioactivity profiles. As one
of the most bioactive isolates, strain Go-475 was subjected to
the liquid-state fermentation (LSF) and the obtained extract also
screened for antimicrobial activities. Interestingly, in contrast to
the extract obtained after SSF no activity against yeasts could be
detected for the extract obtained after LSF, while a significant
activity against Gram-positive B. subtilis was observed for both
extracts (data not shown).
Minimal inhibitory concentration for the Go-475 extract
prepared after SSF was determined for C. albicans and B. subtilis
(see Materials and Methods). The result revealed that MIC for C.
albicans at 100 and 50µg/mL for B. subtilis.
Identification and Structure Elucidation of
the Anti-bacterial Compounds Produced
by Streptomyces sp. Go-475
The methanolic LSF extract of strain Go-475 showing
pronounced activity against B. subtilis was fractionated
FIGURE 1 | Molecular Phylogenetic analysis by Maximum Likelihood method. The evolutionary history was inferred by using the Maximum Likelihood method based
on the Tamura-Nei model (Tamura and Nei, 1993). The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. Evolutionary
analyses were conducted in MEGA7 (Kumar et al., 2016). 16S rDNA sequence of Micromonospora aurantiaca ATCC 27029 was used as an outgroup.
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TABLE 1 | Activity profiles of the crude extracts from selected isolates against Candida albicans and Cryptococcus neoformans, as well as two Gram-positive and three
Gram-negative bacterial pathogens.
Isolate Pathogenic yeasts Gram-positive bacteria Gram-negative bacteria
C. albicans C. neoformans S. aureus B. subtilis E. coli S. typhimurium S. boydi
Ac-006 6 ± 1 5 ± 1 – 6 ± 2 5 ± 1 5 ± 0 –
Ed-065 13 ± 0 11 ± 1 12 ± 1 11 ± 2 – – –
Ac-123 8 ± 1 6 ± 2 – – – – –
Ac-146 7 ± 1 9 ± 2 – – – – –
Ru-355 27 ± 2 28 ± 1 14 ± 1 19 ± 1 18 ± 1 18 ± 1 16 ± 1
Go-475 31 ± 2 27 ± 1 21 ± 2 21 ± 1 – – 11 ± 1
Numbers indicate diameters of inhibition zones (mm).
using Flash chromatography. Fractions 24 (27.41–28.53min)
and 42 (49.20–50.32min) were found to be responsible of the
bioactivity against B. subtilis. These fractions were analyzed
using HPLC-CAD/MS and high resolution LC-MS as described
in Ladurner et al. (2017). Fraction 42 contained several similarly
abundant compounds, which were tentatively identified as
(branched) fatty acids and not further analyzed. In fraction
24, on the other hand, only one major constituent was
detected.
High-resolution ESI-Qq-TOF-MS spectra, obtained by direct
infusion of fraction 24, showed the main compound as [M+H]+
ion at m/z 337.1073 (calculated for C20H17O
+
5 ,m/z 337.1071,
1 = 0.8 ppm) and as [M+Na]+ ion at m/z 359.0891 (calculated
for C20H16O5Na+,m/z 359.0890,1= 0.2 ppm). The HRMS/MS-
spectra of the [M+H]+ ion were not very informative, which
is typical for very stable aromatic systems like angucycline
antibiotics. However, the abundant loss of H2O indicated an
aliphatic hydroxyl-group (see Figures S2, S3). All these data
fit nicely to the known compound 8-O-methyltetrangomycin
(C20H16O5), but due to the lack of a reference standard or
published MS/MS spectra, this preliminary identification could
not be confirmed without further structure elucidation by 1D
and 2D NMR spectroscopy (see Materials and Methods for
details).
When the NMR analysis was executed in deuteromethanol,
we obtained 8-O-methyltetrangomycin (1) as the result,
while measuring the sample in deuterochloroform indicated a
complete conversion to 8-O-methyltetrangulol (2) (Figure 2).
Obviously, the conversion of 1–2 was catalyzed by traces
of hydrochloric acid present in deuterochloroform. Both
compounds showed typical signals of a methoxyanthraquinone
system. The different oxidation state of the six-membered
ring D was indicated in 8-O-methyltetrangomycin by the two
methylene carbons C-2 and C-4, while in 8-O-methyltetrangulol
two olefinc methine signals were detected for C-2 and C-4.
Assignment of the signals was confirmed by COSY, HSQC,
and HMBC measurements. Comparison of the spectral data
of 1 and 2 with literature values confirmed the structure
elucidation (Kesenheimer and Groth, 2006; Ding et al.,
2009).
Streptomyces sp. Go-475 Genome
Analyses
The genome of Streptomyces sp. Go-475 was completely
sequenced (see Materials and Methods for details), revealing a
linear chromosome of 8,570,609 bp, featuring a G+C content
of 71.96%, 7,571 predicted coding sequences, 83 t(m)RNA genes,
and six rrn operons. In addition, a total of 19 RNA features (5′-
UTRs, riboswitches, ncRNAs, etc) were identified based on hits
against RFAM. The inverted terminal repeats of the chromosome
were found to be rather short, with a length of just 6,902 bp,
which is unusual for Streptomyces.
The genome sequence of Streptomyces sp. Go-475 shows
significant sequence similarity to that of Streptomyces olindensis
DAUFPE 5622 (GenBank accession number JJOH00000000),
which is ca 0.8. Mb larger. Apparently, the core genomes
of these two strains are very similar, with the ANI (Average
Nucleotide Identity) of 94.56% over a length of 6,649,500 bp.
Synteny plot of the two genomes (Figure S1, Supporting
Information) clearly demonstrates close relatedness of
Streptomyces sp. Go-475 and S. olindensis, despite the
genome of the latter being rather fragmented (draft quality
sequence). This fact raises the issues of biogeography and
distribution of microorganisms, since these strains were isolated
on two different continents separated by a vast expanse of
water.
Secondary metabolite BGCs were identified in the genome
of Streptomyces sp. Go-475 using antiSMASH 4.02 followed by
manual curation to split apparently disparate BGCs suggested
by the software as being single ones. In total, 36 BGCs were
identified (Table 2), 27 of which were also present in the
genome of S. olindensis DAUFPE 5622 (Rojas et al., 2014).
The latter streptomycete was isolated in 1960s from a soil
sample collected in Brazil, and was shown to produce cytotoxic
glycosylated anthracyclines named cosmomycins. The BGC for
cosmomycin could be readily identified in the genome of
Go-475 (cluster 23, Table 3). Cluster 9, of the ectoine type,
most likely is responsible for the biosynthesis of ectoine and,
possibly, hydroxyectoine and betaine (see next section). Beside
this, BGCs for geosmin (cluster 28) and the angucyclines
(cluster 31, Figure 3) were also identified. The latter cluster is
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FIGURE 2 | Structure of the antibacterial compounds 8-O-methyltetrangomycin (1) and 8-O-methyltetrangulol (2) produced by Streptomyces sp. Go-475.
TABLE 2 | Secondary metabolite biosynthesis gene clusters identified in the genome of Streptomyces sp. Go-475 with antiSMASH 4.02 (manually curated).
No Cluster type Presence in another bacterium Putative product
1 PKSI-NRPS Streptomyces olindensis DAUFPE 5622 Glycosylated PK-NRS peptide hybrid
2 Melanin Multiple Streptomyces spp. Melanin
3 Nrps Streptomyces olindensis DAUFPE 5622 NRS peptide
4 Unknown Streptomyces olindensis DAUFPE 5622 Amino acid-based product
5 Terpene Streptomyces olindensis DAUFPE 5622 Putative sesquiterpene
6 Lantipeptide Streptomyces viridochromogenes DSM 40736 SapB/AmfS family lantipeptide
7 PKSIII Streptomyces sp. XY006 1,3,6,8-tetrahydroxynaphthalene
8 Lassopeptide Streptomyces olindensis DAUFPE 5622 Lassopeptide
9 Ectoine Streptomyces olindensis DAUFPE 5622 Ectoine, betaine
10 Terpene Streptomyces olindensis DAUFPE 5622 Putative isoprenoid
11 PKSI-NRPS Streptomyces chartreusis NRRL 12338 PK-NRS peptide hybrid
12 NRPS Streptomyces olindensis DAUFPE 5622 Glycosylated NRS peptide
13 Terpene Streptomyces olindensis DAUFPE 5622 Isoprenoid
14 Melanin Streptomyces sp. S10(2016) Melanin
15 Lassopeptide Streptomyces chartreusis NRRL 12338 Lassopeptide
16 Siderophore Multiple Streptomyces spp. Desferrioxamine B
17 Butyrolactone Streptomyces olindensis DAUFPE 5622 Butyrolactone
18 PKSI-NRPS Streptomyces olindensis DAUFPE 5622 PK-NRS peptide hybrid
19 Phosphonate Streptomyces olindensis DAUFPE 5622 Phosphonate metabolite
20 Terpene – Terpenoid
21 Aminocyclitol Streptomyces olindensis DAUFPE 5622 Aminocyclitol
22 NRPS Streptomyces vitaminophilus DSM 41686 NRS peptide
23 PKSII Streptomyces olindensis DAUFPE 5622 Cosmomycins
24 Terpene Streptomyces olindensis DAUFPE 5622 Albaflavenone
25 Terpene – Terpenoid (polyprenyl)
26 Siderophore Streptomyces olindensis DAUFPE 5622 Siderophore
27 Bacteriocin Streptomyces olindensis DAUFPE 5622 Bacteriocin
28 Terpene Multiple Streptomyces spp. Geosmin
29 PKSI-NRPS Streptomyces africanus DSM 41829 PK-NRS peptide hybrid
30 Siderophore Streptomyces olindensis DAUFPE 5622 Siderophore
31 PKSII – Angucyclines
32 Terpene Streptomyces olindensis DAUFPE 5622 Hopanoids
33 PKSI Streptomyces olindensis DAUFPE 5622 PK
34 Bacteriocin Multiple Streptomyces spp. Bacteriocin
35 Lantipeptide Multiple Streptomyces spp. SapB/AmfS family lantipeptide
36 PKSI Streptomyces olindensis DAUFPE 5622 PK
NRS, non-ribosomally synthesized; PK, polyketide. Shaded cells show gene clusters not present in the genome of S. olindensis DAUPFE 5622. Products in bold text are inferred with
certainty based on >90% identity of the gene products to those of the verified gene clusters or experimental data (e.g., angucyclines).
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TABLE 3 | Compounds tentatively identified by high-resolution LC-MS in the
crude extracts of Streptomyces sp. Go-475 after liquid (LSF) and solid (SSF)
media fermentations.
No Accurate
mass, Da
Compound ID Type of fermentation
LSF SSF
1 142.0745 Ectoine + +
2 158.0694 Hydroxyectoine + +
3 1180.5236 Anthracycline antibiotic + +
4 1184.5536 Anthracycline antibiotic + +
5 1188.5830 Cosmomycin D + +
6 117.0794 Betaine +
7 898.4480 Anthracycline antibiotic +
8 912.4634 Anthracycline antibiotic +
9 928.4586 Anthracycline antibiotic +
10 944.4530 Anthracycline antibiotic +
11 960.4478 Anthracycline antibiotic +
12 755.3508 Cosmomycin A +
13 771.3462 Cosmomycin B +
14 787.3409 Anthracycline antibiotic +
15 801.3566 Anthracycline antibiotic +
16 336.1008 8-O-Methyltetrangomycin +
17 164.0474 4-Methoxy-1(3H)-
isobenzofuranone*
+
18 150.0682 3-Phenylpropionic acid* +
19 318.0897 8-O-Methyltetrangulol + +
20 218.1675 Albaflavenone + +
21 292.1674 Dehydrocineromycin B* +
Data presented in the order of the retention time in LC. Compounds in bold font have been
confirmed by NMR-assisted structure elucidation.*Not supported by genome analysis.
apparently absent in the S. olindensis genome, and contains
genes encoding polyketide synthases type II (PKSII) along
with some modification enzymes. Interestingly, although the
BGC for both angucyclines were previously identified (Hong
et al., 1997), and core genes identified for this type of
compounds (Palmu et al., 2007) most of their products showed
<80% homology to the corresponding enzymes encoded by
cluster 31. The latter cluster also contains some unique genes
not found in other angucycline BGCs (Table 4), suggesting
that 8-O-methyltetrangomycin and 8-O-methyltetrangulol (see
below) could be mere precursors for more complex novel
compounds. Based on the gene annotation for cluster 31
and current knowledge on the biosynthesis of angucyclines,
a biosynthetic pathway leading to 8-O-methyltetrangomycin
could be suggested (Figure 3). The building blocks needed for
the biosynthesis, malonyl-CoAs, are likely to be afforded via
carboxylation of acetyl-CoA by ORF4, ORF11, and ORF12. The
minimal polyketide synthase II (ORFs 6,7, and 8) performs
a decarboxylative condensation of the acetate units into a
poyketide chain, which undergoes reduction by ORF9 and
cyclization/dehydration by ORF5 resulting in the formation of
the first aromatic ring. Subsequent cyclizations by ORF10 lead
to the formation of an angucycline core. Further modification
steps are likely to be accomplished by oxygenases ORF13/ORF14
and oxidoreductases ORF15/ORF20 to afford tetrangomycin.
ORF18 performs O-methylation of tetrangomycin at position
C8 using S-adenosylmethionine, synthesized by ORF22, as
a methyl group donor to generate compound 1. The latter
is spontaneously converted to 2 in the presence of an
acid.
The genome of isolate Go-475 harbors several BGCs,
homologs of which could not be identified in other genomes
available in the public databases. These include the above
mentioned angucycline BGC, as well as clusters 20 and 25
containing terpene synthase genes. Terpene synthase encoded
by cluster 20 is highly unusual in that it contains a N-
terminal carboxypeptidase regulatory-like domain, while its
terpene cyclase domain shares only 76% homology with the best
database hit. This BGC also encodes a putative trans-isoprenyl
diphosphate synthase, which may provide precursor for the
cognate terpene cyclase.
Cluster 25 contains genes encoding polyprenyl synthase
(only 67% identity to the closest match in the database),
IspH homolog (last enzyme in isopentenyl pyrophosphate
biosynthesis), methyltransferase, prenyltransferase, and MFS
superfamily transporter. It is not clear at the moment, what kind
of terpenoid is specified by this BGC.
Analytical LC-MS Profiles of Methanol
Extracts of the Isolate Go-475
Since the extracts of Streptomyces sp. Go-475 displayed high
antimicrobial activities, which differed depending on the mode
of fermentation (solid or liquid media), we decided to investigate
both extracts using high-resolution LC-MS (see Experimental
Procedures for details). The data were analyzed in two different
ways, untargeted and targeted. First, the mass spectra of all
main compounds were interpreted and potential sum formulae
predicted. Both the accurate masses and predicted chemical
formulae were then queried against the Dictionary of Natural
Products (DNP, contains data on ca. 250.000 natural products).
Secondly, metabolites that were predicted based on homology
of the sequenced BGCs to known ones, namely cahuitamycins
A-C, desferrioxamine B, cosmomycin D, flaviolin, albaflavenone,
ectoine, and betaine, were searched for by creating extracted ion
chromatograms of the corresponding [M+H]+ (for all of them),
[M+2H]2+ (for cosmomycin D), and [M-H]− (for flaviolin and
ectoine) ions. The results of this analysis are presented in Table 3
and Table S5.
As expected from the identified PKSII (clusters 23 and 31),
numerous anthracyclines could be identified, which are most
likely responsible for the activity against Gram-positive bacteria.
Besides compounds matching the sum formulae of derivatives of
tetrangulol (Kuntsmann andMitscher, 1966) and of cosmomycin
A, B, and C, several other potential anthracyclines, whose
assignment was ambiguous or which could not be matched
to known compounds in the DNP, were detected. Production
of the known secondary metabolite 8-O-methyltetrangomycin
(Shigihara et al., 1988) could only be detected in the LSF extract.
However, previous studies showed non-enzymatic conversion
Frontiers in Microbiology | www.frontiersin.org 8 June 2018 | Volume 9 | Article 1270
Kibret et al. Bioactive Streptomyces spp. From Ethiopia
FIGURE 3 | Organization of Streptomyces sp. Go-475 cluster 31 presumably involved in angucycline biosynthesis, and suggested biosynthetic pathway up to
8-O-methyltratrangomycin.
of 8-O-methyltetrangomycin (1) to 8-O-methyltetrangulol (2)
(Figure 2) under acidic conditions, so that this finding does not
necessarily reflect differences in the biosynthesis (Grabley et al.,
1991).
Furthermore, the known osmolytes ectoine, hydroxyectoine,
and betaine, which serve as osmotic stress protectants, were
tentatively identified by MS analyses. All the above mentioned
compounds except 8-O-methyltetrangulol were much more
abundant or exclusively found in the LSF extract. However, this
might be due to different extraction efficiencies for these very
polar compounds between the liquid and solid medium and does
not necessarily reflect altered biosynthesis.
From the remaining predicted compounds, only
albaflavenone could be tentatively identified with low abundance.
On the other hand, three of the main compounds produced
during SSF of strain Go-475 matched to known secondary
metabolites reported from Streptomyces spp., namely 4-
methoxy-1(3H)-isobenzofuranone, 3-phenylpropionic acid,
and dehydrocineromycin B. However, no BGCs in the genome
could be associated with these three compounds. While an
unusual mode of biosynthesis of these metabolites, which made
it impossible to unequivocally propose their BGCs, cannot be
excluded, it is much more likely that they represent false positive
hits at the DNP, which would not be surprising considering
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TABLE 4 | Characteristics of the gene cluster 31 of Streptomyces sp. Go-475
presumably involved in the biosynthesis of 8-O-Methyltetrangomycin.
Gene Putative product Putative function
orf1 TetR family transcriptional
regulator
Efflux regulation
orf2 MFS family transporter Compounds’ efflux
orf3 Response regulator, LuxR family Regulation of biosynthesis
orf4 Acetyl-CoA carboxylase Biosynthesis of malonyl-CoA
orf5 Polyketide cyclase Cyclization of the polyketide
chain
orf6 Beta-ketoacyl synthase Polyketide biosynthesis
orf7 Beta-ketoacyl synthase CLF Polyketide chain length factor
orf8 Acyl carrier protein Polyketide biosynthesis
orf9 3-oxoacyl-ACP reductase 1st reductive step in angucycline
biosynthesis
orf10 Polyketide cyclase 1st cyclization/dehydration
orf11 acyl-CoA carboxylase subunit
beta
Biosynthesis of malonyl-CoA
orf12 acyl-CoA carboxylase subunit
epsilon
Biosynthesis of malonyl-CoA
orf13 Monooxygenase FAD-binding Oxygenation at C12?
orf14 Monooxygenase FAD-binding Oxygenation at C12?
orf15 SDR oxidoreductase unknown
orf16 MFS family transporter Compounds’ efflux
orf17 Antibiotic biosynthesis
monooxygenase
unknown
orf18 O-methyltransferase Conversion of Tetrangomycin to
8-O-methyltatrangomycin
orf19 Antibiotic biosynthesis
monooxygenase
unknown
orf20 SDR oxidoreductase unknown
orf21 Antibiotic biosynthesis
monooxygenase
unknown
orf22 S-adenosylmethionine
synthetase
Provision of a methyl donor for
O-methyltransferase (ORF18)
their rather common sum formulae. Most likely, they represent
previously undetected cosmomycin analogs or precursors.
In addition to the tentatively identified compounds listed in
Table 3 and obvious primary metabolites, such as fatty acids
and their derivatives, extracts from both LSF and SSF contained
a number of substances that could not be identified using
DNP query (data not shown). Notably, there were many more
such compounds in the SSF extract compared to those in the
LSF extract. As suggested by the high number of BGCs that
cannot be linked to known molecules, some of these unidentified
substances might be novel and warrant further studies with
regard to their origins and bioactivities. In particular, none of
the tentatively identified secondary metabolites could be clearly
associated with the strong antifungal activity shown for the SSF
extract, suggesting that a novel compound might be responsible
for this bioactivity.
DISCUSSION
The threat of resistance of infectious agents to currently available
antibiotics has become a global challenge, particularly in the
developing world (Demain, 2009; Berdy, 2012; Hamers et al.,
2012). The current study was focused on the isolation and
characterization of actinomycetes from previously unstudied
habitats in Ethiopia in hope to identify new antimicrobial
agents. Several bioactive isolates originating from different
locations were taxonomically identified and their extended
antimicrobial spectra investigated. Characterization of bioactive
isolates revealed them being dominated by the representatives of
the genus Streptomyces. Likewise, previous studies reported that
members of the genus Streptomyces isolated from the terrestrial
or aquatic environments are responsible for the highest share
(in terms of novelty and frequency) of antimicrobial substance
production (Basilio et al., 2003; Berdy, 2005; Bruntner et al., 2005;
Demain, 2009; Rao et al., 2012). This pronounced antimicrobial
production capacity in the genus Streptomycesmight be related to
the presence of multiple secondary metabolite BGCs in relatively
large genomes, ranging in size from ca 6 to 11Mb (Nett et al.,
2009).
From the six selected Ethiopian isolates, the best ones in
terms of activity spectra were Streptomyces spp. Go-475 and
Ru-355 isolated from Gode (in Somali region) and Ataye (Rift
valley area, in Amhara region), respectively. The extract from
isolate Go-475 showed considerable activities against Gram-
positive bacteria such as S. aureus and B. subtilis, while Ru-
355 was also active against the Gram-negative bacteria E.
coli and S. typhimurium. It is also worth noting that two
isolates, Ac-146 and Ed-065, displaying 100% identical 16S rRNA
gene sequences, have different bioactivity profiles (Table 2).
This suggests that the environment where the strains were
isolated influenced their secondary metabolite biosynthesis
potential, most likely via acquisition of specific biosynthetic
gene clusters. A similar trend was demonstrated for the
marine actinomycete Salinispora, where extensive horizontal
gene transfer was shown to account for the majority of
secondary metabolite biosynthetic pathways (Ziemert et al.,
2014).
In this work, we have focused on the identification of
antibiotics produced by the isolate Go-475. First, the compounds
active against B. subtilis were purified from the liquid culture
of this isolate, and their chemical structures determined by
NMR. Both compounds, identified as 8-O-methyltetrangomycin
(1) and 8-O-methyltetrangulol (2) have been described earlier
(Shigihara et al., 1988). Published bioactivity data for these
compounds (MIC> 100µg/mL and > 50µg/mL for 1 and 2,
respectively, against C. albicans; 100µg/mL and 12.5µg/mL,
respectively, for the same compounds against B. subtilis) and
our own MIC data for crude extract suggest, that other
compounds in the extract may also contribute to its bioactivity.
To gain a deeper insight into the secondary metabolite profiles
of Go-475, this isolate was grown on solid (SSF) and in
liquid media (LSF), and the extracts from these cultures were
compared using LC-MS analysis. As expected, the metabolite
profiles of the extracts were quite different, and, using high-
resolution MS, we were able both, to identify known and
detect potentially unknown metabolites. Notably, considerably
more presumably novel secondary metabolites were found in
the SSF extract suggesting that this method of cultivation
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shall be further exploited in the future bioprospecting efforts.
The most probable explanation for this observation is that
streptomycetes in soils usually dwell on solid particles also
occupied by other microorganisms, with whom they compete
for nutritional sources. It thus appears likely, that they tend to
produce a wider array of bioactive secondary metabolites in SSF,
where conditions more closely resemble native ones compared to
artificial LSF.
Genome sequencing and analysis of the isolate Go-475
revealed a linear chromosome, typical for streptomycetes.
However, it is noteworthy, that terminal inverted repeats of
the Go-475 chromosome are unusually short, ca 7 kb, while in
other streptomycetes they range from 30 kb to 1Mb (Chen et al.,
2002; unpublished data). At least 36 BGCs could be identified
in the genome, some of which appear to be unique, and may
encode novel secondarymetabolites. Even seemingly known gene
clusters, e.g., that for angucyclines biosynthesis, contain unique
additional genes, which may be implicated in modifications
never before seen for this kind of molecules. Interestingly, the
majority of the BGCs are present in a streptomycete isolated from
Brazilian soil, raising interesting questions regarding distribution
of a common ancestor of these bacteria.
CONCLUSION
This study demonstrates for the first time the potential of
streptomycetes isolated from unique environmental niches in
Ethiopia to produce antimicrobial compounds. This work also
sets a stage for a comprehensive investigation of Streptomyces
sp. Go-475, as well as other Ethiopian isolates, in terms of
identification and characterization of new bioactive secondary
metabolites and their biosynthetic gene clusters. In particular,
unique biosynthetic gene clusters, which have not been
previously detected in bacteria, may become targets for genome
mining via heterologous expression or activation aimed at
discovery of newmolecules with therapeutic potential. Moreover,
high degree of similarity between the genomes of Go-475 isolate
and a streptomycete isolated in Brazil raises interesting questions
about biogeographical distribution of these bacteria. Noteworthy
is the number of identical secondary metabolite BGCs present
in these bacteria, suggesting that these play an important role in
their life styles irrespective of the environments.
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